SynthesisDrug design, development and therapy2015

A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.

Fei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.